Potent antitumor activity of double‐regulated oncolytic adenovirus‐mediated ST13 for colorectal cancer
Open Access
- 30 March 2009
- journal article
- Published by Wiley in Cancer Science
- Vol. 100 (4) , 678-683
Abstract
Following targeted gene virotherapy, the suppression of tumorigenicity 13 (ST13) gene was inserted into the double‐regulated oncolytic adenovirus SG500 to ensure more safety and potent antitumor activity against colorectal cancer in vitro and in vivo. We generated the ST13‐expressing oncolytic adenovirus SG500‐ST13, with which colorectal carcinoma cell lines SW620 and HCT116, and the lung fibroblast cell line WI38, were infected. Crystal violet staining was carried out to detect the cytopathic effect in cells, and the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide method was used to assay cell viability. The effect of apoptosis induced by SG500‐ST13 was confirmed by Hoechst staining and the TdT‐mediated dUTP‐biotin nick‐end labeling method. To further identify the antitumor effects of SG500‐ST13 on HCT116 xenografts in Balb/c nude mice, the induction of cell death was assessed by hematoxylin–eosin staining. Immunohistochemical study was also carried out. (Cancer Sci 2009; 100: 678–683)Keywords
This publication has 27 references indexed in Scilit:
- Reciprocal relationship between expression of hypoxia inducible factor 1α (HIF-1α) and the pro-apoptotic protein Bid in ex vivo colorectal cancerBritish Journal of Cancer, 2008
- Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agentsFrontiers in Bioscience-Landmark, 2008
- A simplified system for generating oncolytic adenovirus vector carrying one or two transgenesCancer Gene Therapy, 2007
- What we know about ST13, a co-factor of heat shock protein, or a tumor suppressor?Journal of Zhejiang University-SCIENCE B, 2007
- Proteolysis of HIP during apoptosis occurs within a region similar to the BID loopApoptosis, 2006
- Evaluation of ST13 gene expression in colorectal cancer patientsJournal of Zhejiang University-SCIENCE B, 2005
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Ad-mTERT-Δ19, a Conditional Replication-Competent Adenovirus Driven by the Human Telomerase Promoter, Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific MannerHuman Gene Therapy, 2003
- Characterization of Functional Domains of the Eukaryotic Co-chaperone HipJournal of Biological Chemistry, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994